
### [NCIT:C3247](http://purl.obolibrary.org/obo/NCIT_C3247)
**Label:** Myelodysplastic Syndrome

**Subclasses:** [NCIT:C7506](http://purl.obolibrary.org/obo/NCIT_C7506) (Myelodysplastic Syndrome with Excess Blasts), [NCIT:C6867](http://purl.obolibrary.org/obo/NCIT_C6867) (Myelodysplastic Syndrome with Isolated del(5q)), [NCIT:C2872](http://purl.obolibrary.org/obo/NCIT_C2872) (Refractory Anemia), [NCIT:C97310](http://purl.obolibrary.org/obo/NCIT_C97310) (Myelodysplastic Syndrome with Gene Mutation), [NCIT:C4036](http://purl.obolibrary.org/obo/NCIT_C4036) (Myelodysplastic Syndrome with Ring Sideroblasts), [NCIT:C8648](http://purl.obolibrary.org/obo/NCIT_C8648) (Myelodysplastic Syndrome, Unclassifiable), [NCIT:C130037](http://purl.obolibrary.org/obo/NCIT_C130037) (Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia), [NCIT:C27726](http://purl.obolibrary.org/obo/NCIT_C27726) (Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia), [NCIT:C7168](http://purl.obolibrary.org/obo/NCIT_C7168) (Myelodysplastic Syndrome with Excess Blasts-2), [NCIT:C7167](http://purl.obolibrary.org/obo/NCIT_C7167) (Myelodysplastic Syndrome with Excess Blasts-1), [NCIT:C7643](http://purl.obolibrary.org/obo/NCIT_C7643) (Alkylating Agent-Related Myelodysplastic Syndrome), [NCIT:C7642](http://purl.obolibrary.org/obo/NCIT_C7642) (Epipodophyllotoxin-Related Myelodysplastic Syndrome), [NCIT:C115153](http://purl.obolibrary.org/obo/NCIT_C115153) (Adult Myelodysplastic Syndrome), [NCIT:C27722](http://purl.obolibrary.org/obo/NCIT_C27722) (Therapy-Related Myelodysplastic Syndrome), [NCIT:C8574](http://purl.obolibrary.org/obo/NCIT_C8574) (Myelodysplastic Syndrome with Multilineage Dysplasia), [NCIT:C122686](http://purl.obolibrary.org/obo/NCIT_C122686) (Hypocellular Myelodysplastic Syndrome), [NCIT:C82591](http://purl.obolibrary.org/obo/NCIT_C82591) (Myelodysplastic Syndrome with Single Lineage Dysplasia), [NCIT:C68744](http://purl.obolibrary.org/obo/NCIT_C68744) (Childhood Myelodysplastic Syndrome), [NCIT:C82593](http://purl.obolibrary.org/obo/NCIT_C82593) (Refractory Neutropenia), [NCIT:C82594](http://purl.obolibrary.org/obo/NCIT_C82594) (Refractory Thrombocytopenia), [NCIT:C82595](http://purl.obolibrary.org/obo/NCIT_C82595) (Myelodysplastic Syndrome with Excess Blasts and Fibrosis), [NCIT:C82596](http://purl.obolibrary.org/obo/NCIT_C82596) (Refractory Cytopenia of Childhood), [NCIT:C27280](http://purl.obolibrary.org/obo/NCIT_C27280) (Secondary Myelodysplastic Syndrome), 

**Class expressions from DL-Learner:**

- Thing 52.77%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 39.52%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39873](http://purl.obolibrary.org/obo/NCIT_C39873) (Urethral Glandular Metaplasia))) 39.52%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39872](http://purl.obolibrary.org/obo/NCIT_C39872) (Urethral Villous Adenoma))) 39.52%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39866](http://purl.obolibrary.org/obo/NCIT_C39866) (Female Urethral Malignant Neoplasm))) 39.52%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39864](http://purl.obolibrary.org/obo/NCIT_C39864) (Carcinoma of Cowper Glands))) 39.52%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39862](http://purl.obolibrary.org/obo/NCIT_C39862) (Human Papillomavirus-Related Urethral Squamous Cell Carcinoma))) 39.52%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39859](http://purl.obolibrary.org/obo/NCIT_C39859) (Bladder Inverted Papilloma))) 39.52%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39856](http://purl.obolibrary.org/obo/NCIT_C39856) (Urothelial Dysplasia))) 39.52%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39845](http://purl.obolibrary.org/obo/NCIT_C39845) (Bladder Urachal Squamous Cell Carcinoma))) 39.52%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39844](http://purl.obolibrary.org/obo/NCIT_C39844) (Bladder Urachal Urothelial Carcinoma))) 39.52%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39834](http://purl.obolibrary.org/obo/NCIT_C39834) (Bladder Squamous Papilloma))) 39.52%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39833](http://purl.obolibrary.org/obo/NCIT_C39833) (Schistosoma Hematobium-Related Bladder Verrucous Carcinoma))) 39.52%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39829](http://purl.obolibrary.org/obo/NCIT_C39829) (Infiltrating Bladder Urothelial Carcinoma with Giant Cells))) 39.52%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39826](http://purl.obolibrary.org/obo/NCIT_C39826) (Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant without Heterologous Elements))) 39.52%


